Moberg Pharma's Interim Report for July 2019 - March 2020 to be Published on May 12 - Invitation to Teleconference
STOCKHOLM, May 5, 2020 /PRNewswire/ -- On May 12th, 2020, at 08:00 am (CET), Moberg Pharma AB (OMX: MOB) will present its Interim report for July 2019 - March 2020. Investors, analysts and journalists are hereby invited to participate in a teleconference at 3:00 pm (CET) on the same date.
The teleconference will be hosted by Moberg Pharmas's CEO Anna Ljung and VP Finance Mark Beveridge. The presentation will be held in English.
Date: May 12th, 2020
Time: 3:00 pm (CET)
To participate in the conference, please dial in on any number below before the start of the call:
SE: +46 8 505 583 69
US: +1 833 249 84 04
The quarterly report and other information material will be made public on:
http://www.mobergpharma.com/investors/calendarpresentations
For additional information, please contact:
Anna Ljung, CEO, Phone: + 46 70 766 60 30, e-post: [email protected]
Mark Beveridge, VP Finance, Phone: + 46 76 805 82 88, e-post: [email protected]
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Invitation to teleconference 12th of May |
SOURCE Moberg Pharma
![](https://rt.prnewswire.com/rt.gif?NewsItemId=IO97896&Transmission_Id=202005050214PR_NEWS_USPR_____IO97896&DateId=20200505)
Share this article